Public-Private Partnerships Praised Amid Criticism of COVID-19 Response

A US House Oversight Committee report criticizes the government's COVID-19 response, including PPE shortages and issues with the CDC’s test development process. However, it praises the successful public-private partnerships in developing diagnostics, emphasizing the importance of leveraging private industry expertise for future pandemic preparedness.

Covid test

A blistering report from the US House Oversight Committee found significant flaws throughout the government’s handling of the COVID-19 pandemic, including the supply chain issues that led to protective equipment (PPE) shortages. At the same time, the report also praised the public-private partnerships around diagnostics development.

Much of the 557-page report, which was compiled by a select subcommittee headed by Rep

Key Takeaways

The US House Oversight Committee's report highlights significant flaws in the government's handling of the COVID-19 pandemic, including in managing supplies of personal protective equipment and the CDC's test development process.

The report states that the Strategic National Stockpile (SNS) was understocked and unprepared to address a nationwide viral epidemic. It suggests that the SNS should be supplemented with state-managed stockpiles to ensure quicker distribution of resources

More from Medtech Insight

More from Legislation